financetom
Business
financetom
/
Business
/
Caesars Entertainment Insider Bought Shares Worth $621,750, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Caesars Entertainment Insider Bought Shares Worth $621,750, According to a Recent SEC Filing
Mar 7, 2024 2:09 PM

04:47 PM EST, 03/07/2024 (MT Newswires) -- Michael E Pegram, Director, on March 06, 2024, executed a purchase for 15,000 shares in Caesars Entertainment ( CZR ) for $621,750. Following the Form 4 filing with the SEC, Pegram has control over a total of 161,309 shares of the company, with 4,612 shares held directly and 156,697 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1590895/000159089524000077/xslF345X03/wk-form4_1709847681.xml

Price: 41.94, Change: +0.25, Percent Change: +0.6

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coinbase Shares Tumble With Bitcoin: What's Going On With The Stock?
Coinbase Shares Tumble With Bitcoin: What's Going On With The Stock?
Jun 24, 2024
Coinbase Global, Inc. ( COIN ) shares are trading lower Monday after the price of Bitcoin fell below $62,000.  The Details: Bitcoin is down by nearly 5% over the past 24 hours, and Coinbase shares are moving lower as bitcoin retreats.  Investors are looking to the possible approval of a spot Ethereum (CRYPTO: ETH) ETF as the next potential cryptocurrency...
Anixa Biosciences Says Sixth Patient Treated in Phase 1 Ovarian Cancer Study
Anixa Biosciences Says Sixth Patient Treated in Phase 1 Ovarian Cancer Study
Jun 24, 2024
11:03 AM EDT, 06/24/2024 (MT Newswires) -- Anixa Biosciences ( ANIX ) said Monday it has treated the sixth patient in its phase 1 clinical study of a potential chimeric antigen receptor T-cell therapy for ovarian cancer. The patient is anticipated to be the last patient in the second dosage group, the biotechnology company said. Anixa said it would start...
Market Chatter: Carlyle, Goldman Sachs Lend $1.1 Billion Payment-in-Kind Note to Apex Group
Market Chatter: Carlyle, Goldman Sachs Lend $1.1 Billion Payment-in-Kind Note to Apex Group
Jun 24, 2024
11:05 AM EDT, 06/24/2024 (MT Newswires) -- Carlyle Group ( CG ) and Goldman Sachs' ( GS ) private credit platform have lent a $1.1 billion payment-in-kind note to Apex Group, Bloomberg News reported Monday, citing a statement from the firm. The funding is expected to support growth, the report added, citing the statement. Carlyle, Goldman Sachs ( GS )...
GE HealthCare Partners With New Mexico Hospital to Install Allia IGS Pulse Electrophysiology Lab
GE HealthCare Partners With New Mexico Hospital to Install Allia IGS Pulse Electrophysiology Lab
Jun 24, 2024
11:04 AM EDT, 06/24/2024 (MT Newswires) -- GE HealthCare Technologies ( GEHC ) and Heart Hospital of New Mexico at Lovelace Medical Center said Monday they have teamed up for the first US installation of the company's latest Allia Image Guided System Pulse. They said the hospital will use the system in its cardiac electrophysiology lab to plan, guide and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved